These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19828369)

  • 21. Clinical and economic considerations of vaccination against varicella.
    Strassels SA; Sullivan SD
    Pharmacotherapy; 1997; 17(1):133-9. PubMed ID: 9017774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An economic analysis of the universal varicella vaccination program in the United States.
    Zhou F; Ortega-Sanchez IR; Guris D; Shefer A; Lieu T; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S156-64. PubMed ID: 18419391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chickenpox in pregnancy: revisited.
    Tan MP; Koren G
    Reprod Toxicol; 2006 May; 21(4):410-20. PubMed ID: 15979274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia.
    Khandaker G; Marshall H; Peadon E; Zurynski Y; Burgner D; Buttery J; Gold M; Nissen M; Elliott EJ; Burgess M; Booy R
    Arch Dis Child; 2011 May; 96(5):453-6. PubMed ID: 21349886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of VariZIG in pregnancy.
    Bapat P; Koren G
    Expert Rev Vaccines; 2013 Nov; 12(11):1243-8. PubMed ID: 24093779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology.
    Goldman GS
    Vaccine; 2005 May; 23(25):3349-55. PubMed ID: 15837242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
    Celikbas A; Ergonul O; Aksaray S; Tuygun N; Esener H; Tanir G; Eren S; Baykam N; Guvener E; Dokuzoguz B
    Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varicella: complications and costs.
    Preblud SR
    Pediatrics; 1986 Oct; 78(4 Pt 2):728-35. PubMed ID: 3093966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of the presumed susceptible varicella (chickenpox)-exposed gravida: a cost-effectiveness/cost-benefit analysis.
    Rouse DJ; Gardner M; Allen SJ; Goldenberg RL
    Obstet Gynecol; 1996 Jun; 87(6):932-6. PubMed ID: 8649701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Varicella during pregnancy. 2. Diagnosis, prevention and therapy].
    Sauerbrei A; Wutzler P
    Dtsch Med Wochenschr; 2004 Sep; 129(39):2045-7. PubMed ID: 15386208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Incorporation of varicella-zoster virus vaccination in childhood immunization schedules].
    Rothbart H; Rishpon S
    Harefuah; 2008; 147(8-9):693-7, 751, 750. PubMed ID: 18935757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the introduction of universal varicella vaccination in the Netherlands.
    Boot HJ; de Melker HE; Stolk EA; de Wit GA; Kimman TG
    Vaccine; 2006 Sep; 24(37-39):6288-99. PubMed ID: 16790302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varicella during pregnancy. Maternal and fetal effects.
    Katz VL; Kuller JA; McMahon MJ; Warren MA; Wells SR
    West J Med; 1995 Nov; 163(5):446-50. PubMed ID: 8533407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and economic impact of various strategies for varicella immunity screening and vaccination of health care personnel.
    Baracco GJ; Eisert S; Saavedra S; Hirsch P; Marin M; Ortega-Sanchez IR
    Am J Infect Control; 2015 Oct; 43(10):1053-60. PubMed ID: 26138999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic evaluation of varicella vaccination in Spain: results from a dynamic model.
    Lenne X; Diez Domingo J; Gil A; Ridao M; Lluch JA; Dervaux B
    Vaccine; 2006 Nov; 24(47-48):6980-9. PubMed ID: 16860909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. American Academy of Pediatrics. Committee on Infectious Diseases. Varicella vaccine update.
    Pediatrics; 2000 Jan; 105(1 Pt 1):136-41. PubMed ID: 10617719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effectiveness of vaccination strategies in adults without a history of chickenpox.
    Smith KJ; Roberts MS
    Am J Med; 2000 Jun; 108(9):723-9. PubMed ID: 10924649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The case against universal varicella vaccination.
    Goldman GS
    Int J Toxicol; 2006; 25(5):313-7. PubMed ID: 16940003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey of the status of self-paid varicella vaccination among children one to six years of age in Taiwan.
    Liao SL; Huang T; Huang YC; Jiang DD
    J Microbiol Immunol Infect; 2007 Apr; 40(2):112-5. PubMed ID: 17446958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.